v-Jun Overrides the Mitogen Dependence of S-Phase Entry by Deregulating Retinoblastoma Protein Phosphorylation and E2F-Pocket Protein Interactions as a Consequence of Enhanced Cyclin E-cdk2 Catalytic Activity

REFERENCES

• Amati, B., Alevizopoulos, K., and Vlach, J.. 1998. Myc and the cell cycle. Front. Biosci. 3:D250–D268
   PubMed Web of Science ®Google Scholar
• Bouchard, C., Thieke, K., Maier, A., Saffrich, R., Hanley-Hyde, J., Ansorge, W., Reed, S., Sicinski, P., Bartek, J., and Eilers, M.. 1999. Direct induction of cyclin D2 by myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:5321–5333
   PubMed Web of Science ®Google Scholar
• Buck, V., Allen, K. E., Sorensen, T., Bybee, A., Hijmans, E. M., Voorhoeve, P. M., Bernards, R., and La Thangue, N. B.. 1995. Molecular and functional characterisation of E2F-5, a new member of the E2F family. Oncogene 11:31–38
   PubMedGoogle Scholar
• Clark, W., and Gillespie, D. A.. 1997. Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factors. Cell Growth Differ. 8:371–380
   PubMedGoogle Scholar
• Coats, S., Flanagan, W. M., Nourse, J., and Roberts, J. M.. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877–880
   PubMed Web of Science ®Google Scholar
• Dyson, N.. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262
   PubMed Web of Science ®Google Scholar
• Eilers, M., Picard, D., Yamamoto, K. R., and Bishop, J. M.. 1989. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66–68
   PubMedGoogle Scholar
• Fu, S., Bottoli, I., Goller, M., and Vogt, P. K.. 1999. Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. Proc. Natl. Acad. Sci. USA 96:5716–5721
   PubMedGoogle Scholar
• Fuerstenberg, S., Beug, H., Introna, M., Khazaie, K., Munoz, A., Ness, S., Nordstrom, K., Sap, J., Stanley, I., Zenke, M. et al. 1990. Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector. J. Virol. 64:5891–5902
   PubMedGoogle Scholar
• Gao, M., Morgan, I., and Vogt, P. K.. 1996. Differential and antagonistic effects of v-Jun and c-Jun. Cancer Res. 56:4229–4235
   PubMedGoogle Scholar
• Girling, R., Partridge, J. F., Bandara, L. R., Burden, N., Totty, N. F., Hsuan, J. J., and La Thangue, N. B.. 1993. A new component of the transcription factor DRTF1/E2F. Nature 362:83–87
   PubMed Web of Science ®Google Scholar
• Hadman, M., Gabos, L., Loo, M., Sehgal, A., and Bos, T. J.. 1996. Isolation and cloning of JTAP-1: a cathepsin like gene upregulated in response to V-Jun induced cell transformation. Oncogene 12:135–142
   PubMedGoogle Scholar
• Hadman, M., Lin, W., Bush, L., and Bos, T. J.. 1998. Apolipoprotein A-1 is a negative target of v-Jun overexpression. Oncogene 16:655–660
   PubMedGoogle Scholar
• Hartl, M., and Bister, K.. 1998. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation. Oncogene 17:2901–2913
   PubMedGoogle Scholar
• Helin, K.. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28–35
   PubMedGoogle Scholar
• Herber, B., Truss, M., Beato, M., and Muller, R.. 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295–1304
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., and Weinberg, R. A.. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006
   PubMed Web of Science ®Google Scholar
• Hussain, S., Kilbey, A., and Gillespie, D. A.. 1998. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter. Cell Growth Differ. 9:677–686
   PubMedGoogle Scholar
• Jansen-Durr, P.. 1996. How viral oncogenes make the cell cycle. Trends Genet. 12:270–275
   PubMedGoogle Scholar
• Johnson, D. G., Schwarz, J. K., Cress, W. D., and Nevins, J. R.. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349–352
   PubMed Web of Science ®Google Scholar
• Johnson, R. S., van Lingen, B., Papaioannou, V. E., and Spiegelman, B. M.. 1993. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7:1309–1317
   PubMed Web of Science ®Google Scholar
• Kilbey, A., Black, E. J., Unlu, M., and Gillespie, D. A. F.. 1996. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction. Oncogene 12:2409–2418
   PubMedGoogle Scholar
• Kovary, K., and Bravo, R.. 1991. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11:4466–4472
   PubMed Web of Science ®Google Scholar
• Kruse, U., Iacovoni, J. S., Goller, M. E., and Vogt, P. K.. 1997. Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera. Proc. Natl. Acad. Sci. USA 94:12396–12400
   PubMedGoogle Scholar
• Lahti, J. M., Li, H., and Kidd, V. J.. 1997. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. J. Biol. Chem. 272:10859–10869
   PubMed Web of Science ®Google Scholar
• La Rocca, S. A., Crouch, D. H., and Gillespie, D. A.. 1994. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene 9:3499–3508
   PubMed Web of Science ®Google Scholar
• Ludlow, J. W., Shon, J., Pipas, J. M., Livingston, D. M., and DeCaprio, J. A.. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387–396
   PubMed Web of Science ®Google Scholar
• Lukas, J., Bartkova, J., Rohde, M., Strauss, M., and Bartek, J.. 1995. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600–2611
   PubMed Web of Science ®Google Scholar
• Lukas, J., Petersen, B. O., Holm, K., Bartek, J., and Helin, K.. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16:1047–1057
   PubMed Web of Science ®Google Scholar
• Lundberg, A. S., and Weinberg, R. A.. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753–761
   PubMed Web of Science ®Google Scholar
• Maki, Y., Bos, T. J., Davis, C., Starbuck, M., and Vogt, P. K.. 1987. Avian sarcoma virus 17 carries the jun oncogene. Proc. Natl. Acad. Sci. USA 84:2848–2852
   PubMed Web of Science ®Google Scholar
• May, G. H., Funk, M., Black, E. J., Clark, W., Hussain, S., Woodgett, J. R., and Gillespie, D. A.. 1998. An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo. Curr. Biol. 8:117–120
   PubMedGoogle Scholar
• Medema, R. H., Herrera, R. E., Lam, F., and Weinberg, R. A.. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289–6293
   PubMed Web of Science ®Google Scholar
• Mittnacht, S.. 1998. Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8:21–27
   PubMed Web of Science ®Google Scholar
• Morgan, D. O.. 1995. Principles of CDK regulation. Nature 374:131–134
   PubMed Web of Science ®Google Scholar
• Morgan, I. M., Asano, M., Havarstein, L. S., Ishikawa, H., Hiiragi, T., Ito, Y., and Vogt, P. K.. 1993. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication. Oncogene 8:1135–1140
   PubMedGoogle Scholar
• Nead, M. A., Baglia, L. A., Antinore, M. J., Ludlow, J. W., and McCance, D. J.. 1998. Rb binds c-Jun and activates transcription. EMBO J. 17:2342–2352
   PubMedGoogle Scholar
• Okamoto, A., Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W. P., Forrester, K., Gerwin, B., Serrano, M., Beach, D. H. et al. 1994. Mutations and altered expression of p16INK4 in human cancer. Proc. Natl. Acad. Sci. USA 91:11045–11049
   PubMed Web of Science ®Google Scholar
• Perez-Roger, I., Kim, S. H., Griffiths, B., Sewing, A., and Land, H.. 1999. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J. 18:5310–5320
   PubMed Web of Science ®Google Scholar
• Pusch, O., Bernaschek, G., Eilers, M., and Hengstschlager, M.. 1997. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene 15:649–656
   PubMedGoogle Scholar
• Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Muller, R., Ansorge, W., and Eilers, M.. 1996. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J. 15:3065–3076
   PubMed Web of Science ®Google Scholar
• Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P., and Wagner, E. F.. 1999. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13:607–619
   PubMed Web of Science ®Google Scholar
• Sherr, C. J.. 1996. Cancer cell cycles. Science 274:1672–1677
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and Roberts, J. M.. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512
   PubMed Web of Science ®Google Scholar
• Shimizu, M., Nomura, Y., Suzuki, H., Ichikawa, E., Takeuchi, A., Suzuki, M., Nakamura, T., Nakajima, T., and Oda, K.. 1998. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4. Exp. Cell Res. 239:93–103
   PubMedGoogle Scholar
• Smith, E. J., Leone, G., DeGregori, J., Jakoi, L., and Nevins, J. R.. 1996. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol. Cell. Biol. 16:6965–6976
   PubMed Web of Science ®Google Scholar
• Smith, M. J., and Prochownik, E. V.. 1992. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood 79:2107–2115
   PubMedGoogle Scholar
• Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., and Eilers, M.. 1996. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J. 14:4814–4826
   Google Scholar
• Weinberg, R. A.. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330
   PubMed Web of Science ®Google Scholar
• Wisdom, R., Johnson, R. S., and Moore, C.. 1999. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18:188–197
   PubMed Web of Science ®Google Scholar
• Zetterberg, A., Larsson, O., and Wiman, K. G.. 1995. What is the restriction point? Curr. Opin. Cell Biol. 7:835–842
   PubMed Web of Science ®Google Scholar